Zhang et al. used a clinically guided genetic screening approach in triple-negative breast cancer (TNBC) and found that LINP1 is not only highly expressed in TNBC tumor tissues, but also participates in the regulation of the non-homologous end joining (NHEJ) pathway through Ku80 and DNA-PKcs 28. This evidence concerns the gene PRKDC and triple-negative breast carcinoma.